<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ADB14AFF-F6DF-4144-A743-0AAE3D33973D"><gtr:id>ADB14AFF-F6DF-4144-A743-0AAE3D33973D</gtr:id><gtr:name>European Organisation for Research and Treatment of Cancer (EORTC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6878F160-3C35-4AC6-8D56-FBD6D6FB37B4"><gtr:id>6878F160-3C35-4AC6-8D56-FBD6D6FB37B4</gtr:id><gtr:name>Amgen Inc</gtr:name><gtr:address><gtr:line1>One Amgen Center Drive</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/59CCFD7F-1733-4D09-A5FA-192ACC14D8BB"><gtr:id>59CCFD7F-1733-4D09-A5FA-192ACC14D8BB</gtr:id><gtr:name>BioMarin Pharmaceutical</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6ECC3D22-E16E-4425-B167-4251C681C9FA"><gtr:id>6ECC3D22-E16E-4425-B167-4251C681C9FA</gtr:id><gtr:name>Vectura  Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E4E1DAA0-8180-41F1-9351-540577DB2B5F"><gtr:id>E4E1DAA0-8180-41F1-9351-540577DB2B5F</gtr:id><gtr:name>Saarland University</gtr:name><gtr:address><gtr:line1>Main Campus</gtr:line1><gtr:line2>Stuhlsatzenhausweg</gtr:line2><gtr:postCode>D-66123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F4A7D252-A2AA-4FB4-A88D-E15A159E9993"><gtr:id>F4A7D252-A2AA-4FB4-A88D-E15A159E9993</gtr:id><gtr:name>Hub at the MRC/CRUK/BHF Clinical Trial Service Unit</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6726D03A-217B-461A-8939-2057211DF5A5"><gtr:id>6726D03A-217B-461A-8939-2057211DF5A5</gtr:id><gtr:name>MRC North West Hub for Trials Methodology Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B918BE28-4717-429B-9E8C-D72C692349D2"><gtr:id>B918BE28-4717-429B-9E8C-D72C692349D2</gtr:id><gtr:name>NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ADB14AFF-F6DF-4144-A743-0AAE3D33973D"><gtr:id>ADB14AFF-F6DF-4144-A743-0AAE3D33973D</gtr:id><gtr:name>European Organisation for Research and Treatment of Cancer (EORTC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6878F160-3C35-4AC6-8D56-FBD6D6FB37B4"><gtr:id>6878F160-3C35-4AC6-8D56-FBD6D6FB37B4</gtr:id><gtr:name>Amgen Inc</gtr:name><gtr:address><gtr:line1>One Amgen Center Drive</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59CCFD7F-1733-4D09-A5FA-192ACC14D8BB"><gtr:id>59CCFD7F-1733-4D09-A5FA-192ACC14D8BB</gtr:id><gtr:name>BioMarin Pharmaceutical</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1CC23DC2-3991-4123-B5F2-83C1F5793403"><gtr:id>1CC23DC2-3991-4123-B5F2-83C1F5793403</gtr:id><gtr:name>F. Hoffmann-La Roche AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6ECC3D22-E16E-4425-B167-4251C681C9FA"><gtr:id>6ECC3D22-E16E-4425-B167-4251C681C9FA</gtr:id><gtr:name>Vectura  Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E4E1DAA0-8180-41F1-9351-540577DB2B5F"><gtr:id>E4E1DAA0-8180-41F1-9351-540577DB2B5F</gtr:id><gtr:name>Saarland University</gtr:name><gtr:address><gtr:line1>Main Campus</gtr:line1><gtr:line2>Stuhlsatzenhausweg</gtr:line2><gtr:postCode>D-66123</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F4A7D252-A2AA-4FB4-A88D-E15A159E9993"><gtr:id>F4A7D252-A2AA-4FB4-A88D-E15A159E9993</gtr:id><gtr:name>Hub at the MRC/CRUK/BHF Clinical Trial Service Unit</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6726D03A-217B-461A-8939-2057211DF5A5"><gtr:id>6726D03A-217B-461A-8939-2057211DF5A5</gtr:id><gtr:name>MRC North West Hub for Trials Methodology Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B918BE28-4717-429B-9E8C-D72C692349D2"><gtr:id>B918BE28-4717-429B-9E8C-D72C692349D2</gtr:id><gtr:name>NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A415FBFD-F657-4BE1-B8B7-33C8B25DA5E9"><gtr:id>A415FBFD-F657-4BE1-B8B7-33C8B25DA5E9</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Sydes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5F4BE39D-6ED2-4946-AEB1-C681240D3A57"><gtr:id>5F4BE39D-6ED2-4946-AEB1-C681240D3A57</gtr:id><gtr:firstName>Jayne</gtr:firstName><gtr:surname>Tierney</gtr:surname><gtr:orcidId>0000-0002-4734-3014</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12023%2F24"><gtr:id>50591C1A-92F0-4CE0-B0CA-F0CEBE2175A5</gtr:id><gtr:title>Effective and efficient conduct of trials and meta-analyses</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12023/24</gtr:grantReference><gtr:abstractText>Our work in this area involves investigating and improving trial data checking and monitoring, as well as reducing bias and improving the validity of our systematic reviews. Some of the important outcomes are: 
Evidence-based trial monitoring 
? Many trials organisations have implemented trial management and monitoring procedures out of proportion to the risks to trial participants or the public, thereby increasing the workload, complexity and cost of lower-risk trials. We initiated the TEMPER study to evaluate prospectively whether triggered monitoring is effective at distinguishing problem sites in ongoing CTU multicentre cancer trials. 
Increasing participant retention in trials
? Our systematic review of strategies to increase participant retention specifically in RCTs has shown that monetary incentives and offers of monetary incentives increase postal and electronic questionnaire response. Non-monetary incentives, additional communication and reminder strategies and most modified questionnaires have little impact. 
Informing systematic review conduct
? CTU is leading a Network-funded project to develop a ?state of the art? series of papers on Individual participant data (IPD) meta-analyses and recently hosted a workshop of international experts to discuss topics. Most systematic reviews now assess risk of bias of eligible trials based on their publications (often using the Cochrane Collaboration tool), and it has been proposed that these are used as a basis for including or weighting trials in a meta-analysis. An evaluation of publication-based assessments showed that they can be unreliable, compared to those based on information obtained from investigators or protocols (as part of our IPD meta-analyses). In particular, reviewers should be cautious about using these as a basis for trial inclusion, and instead seek additional information from trialists, where possible.</gtr:abstractText><gtr:technicalSummary>There is an urgent need for new methods for many clinical studies. One challenge is finding cost-effective, evidence-based methods for running trials. This increases the likelihood of producing reliable results in a timely manner, which in turn frees resources to allow more trials to take place. We will do this by developing and evaluating methods for ensuring that trials are run effectively and efficiently. We are providing practical examples of how novel designs can be implemented; evaluating and implementing strategies to ensure that data quantity and quality are maximised and that staff time locally and at sites is best used. We are also investigating how to get trials started and reported more quickly, and to make appropriate use of e-health resources.

Gains from efficient conduct may be dissipated or lost completely if evidence synthesis of trials is protracted, inefficient or poorly conducted. Furthermore, if understanding or use of systematic reviews is limited, then clinical practice and research may not be informed by the best evidence. We will address these issues by developing a new framework for meta-analysis to speed up the evaluation of individual therapies; providing tools and guidance to promote greater awareness, understanding and use of IPD meta-analysis across a variety of stakeholders and resolving outstanding issues in systematic review conduct.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>339000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Amgen Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Methodology Research Collaboration with industry</gtr:description><gtr:id>84191D0A-B38E-4023-A782-D93CB0267EE5</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56ced8ec02c142.18830284-3</gtr:outcomeId><gtr:partnerContribution>Commitment to developing research activity in to design, conduct or analysis methodology in areas of mutual interest. Detailed discussions ongoing</gtr:partnerContribution><gtr:piContribution>Commitment to developing research activity in to design, conduct or analysis methodology in areas of mutual interest. Detailed discussions ongoing</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>R20 Workshop and guidance on IPD meta-analysis</gtr:description><gtr:id>BF74F0D1-9E61-4AA3-BB40-814F7DBD127C</gtr:id><gtr:impact>We brought international experts to the Unit to discuss key IPD topics, develop guidance outlines and establish writing committees. We have published four papers.</gtr:impact><gtr:outcomeId>56cdc1e24ceb14.55500952-4</gtr:outcomeId><gtr:partnerContribution>Helping develop the funding proposal, project planning, developing the workshop. Drafting and reviewing subsequent IPD guidance papers.</gtr:partnerContribution><gtr:piContribution>Leading the development of the funding proposal, project planning and organising, developing and running a workshop. Drafting and reviewing subsequent IPD guidance papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>PRISMA-IPD Steering Group</gtr:description><gtr:id>4A6D5050-C25A-4DD9-BC2B-B559B1AFFD68</gtr:id><gtr:impact>Development of reporting guidelines and a checklist for the standardised reporting of systematic reviews and meta-analyses of IPD. This has been published</gtr:impact><gtr:outcomeId>56cdd68274bd68.02249865-3</gtr:outcomeId><gtr:partnerContribution>Expertise and intellectual contribution</gtr:partnerContribution><gtr:piContribution>Expertise and intellectual contribution. Steering Group membership (Jayne Tierney)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>32E788AF-A0C5-407F-8657-228A21662117</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-10</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Hubs for Trial Methodology Research</gtr:department><gtr:description>Evidence Synthesis Working Group</gtr:description><gtr:id>65D17509-5AED-4B37-8252-63D2C6D3267A</gtr:id><gtr:impact>A number of papers are in draft form and a survey (INVEST) of use of evidence synthesis was conducted at the 3rd International Clinical Trials Methodology Conference</gtr:impact><gtr:outcomeId>56cdca846669e8.87919055-1</gtr:outcomeId><gtr:partnerContribution>The Evidence Synthesis Working Group focuses on the use of evidence synthesis, or systematic reviews, in the design, conduct and analysis of trials. The Working Group has prepared a series of papers to help trialists and others to make best use of evidence synthesis.</gtr:partnerContribution><gtr:piContribution>The HTMR Network supports the Evidence Synthesis Working Group (WG) to regularly meet and exchange ideas. This involves members of the methodology community and Hub members.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC All-Ireland Methodology Hub</gtr:department><gtr:description>R20 Workshop and guidance on IPD meta-analysis</gtr:description><gtr:id>C21B9875-2EA9-4588-9BAA-79F206F3A1D3</gtr:id><gtr:impact>We brought international experts to the Unit to discuss key IPD topics, develop guidance outlines and establish writing committees. We have published four papers.</gtr:impact><gtr:outcomeId>56cdc1e24ceb14.55500952-2</gtr:outcomeId><gtr:partnerContribution>Helping develop the funding proposal, project planning, developing the workshop. Drafting and reviewing subsequent IPD guidance papers.</gtr:partnerContribution><gtr:piContribution>Leading the development of the funding proposal, project planning and organising, developing and running a workshop. Drafting and reviewing subsequent IPD guidance papers</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>R20 Workshop and guidance on IPD meta-analysis</gtr:description><gtr:id>4235E682-8928-4B04-8A34-06EA98E597F0</gtr:id><gtr:impact>We brought international experts to the Unit to discuss key IPD topics, develop guidance outlines and establish writing committees. We have published four papers.</gtr:impact><gtr:outcomeId>56cdc1e24ceb14.55500952-1</gtr:outcomeId><gtr:partnerContribution>Helping develop the funding proposal, project planning, developing the workshop. Drafting and reviewing subsequent IPD guidance papers.</gtr:partnerContribution><gtr:piContribution>Leading the development of the funding proposal, project planning and organising, developing and running a workshop. Drafting and reviewing subsequent IPD guidance papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Children and Young People in trials - online learning resource</gtr:description><gtr:id>751EFE5A-F8F5-45B3-A07A-BA9424591AD0</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>5888d665773686.06996855-1</gtr:outcomeId><gtr:partnerContribution>Coordination and overall responsibility for the project.</gtr:partnerContribution><gtr:piContribution>Contributions made to planning of this project, coordinated by researchers at Queens University, Belfast.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>E303F646-2882-4DAF-AFD2-54467DB019E6</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-2</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC ConDuCT Trials Methodology Hub</gtr:department><gtr:description>R34 An ethnographic study of group decision making and member roles in TSC and TMG</gtr:description><gtr:id>1040BFA5-01F6-4344-B0E6-56003790B106</gtr:id><gtr:impact>Two papers have been published and one further paper has been submitted for publication.</gtr:impact><gtr:outcomeId>56cdc88f529b87.96144324-1</gtr:outcomeId><gtr:partnerContribution>Funding given from the MRC Hubs for Trials Methodology Research Network .</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded project to work on An ethnographic study of group decision-making and member roles to understand and improve how Trial Steering Committees and Trial Management Groups contribute to trial conduct&amp;quot;</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Edinburgh Clinical Trials Unit</gtr:department><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>AE5B6BCD-E7F9-4144-94F9-C6C700277E91</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-6</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bayer</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>531140D8-A62F-40B1-9FD3-287B8DD010C3</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-8</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vectura  Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>E134BDCA-6160-49AF-9D23-4E35448F8B5B</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-11</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Network of Hubs for Trials Methodology Research (HTMR)</gtr:department><gtr:description>R39 Agreeing current good practice for clinical trial data access and sharing</gtr:description><gtr:id>BE050C20-1964-40D2-A97C-EDDF87B930B1</gtr:id><gtr:impact>Two papers published giving views on data sharing, rationale and examples</gtr:impact><gtr:outcomeId>56cdc80a144730.74764173-2</gtr:outcomeId><gtr:partnerContribution>MRC Hubs for Trials Methodology Research Network funding provided for project commencement</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded proposal addresses a main priority area for the HTMR Network, that of using existing evidence in the prioritisation, design and planning, conduct, and interpretation of trials, all of which can be helped by improving access to clinical trial data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>R25- Remits, roles and working models for Trial Steering Committees and Data Monitoring Committees in clinical trials evaluating diagnostic tests, most notably test accuracy studies.</gtr:description><gtr:id>207164A6-1970-4700-A05D-5606E341F24F</gtr:id><gtr:impact>Review, workshop and expert consensus expected. Collaborative work underway.</gtr:impact><gtr:outcomeId>56cdc364a27a12.81981244-1</gtr:outcomeId><gtr:partnerContribution>Review, workshop and expert consensus expected in 2015</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded proposal project- links in with a suite of Network research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC All-Ireland Methodology Hub</gtr:department><gtr:description>PRISMA-IPD Steering Group</gtr:description><gtr:id>5C067A07-2AC7-471A-B612-43FF80736EB3</gtr:id><gtr:impact>Development of reporting guidelines and a checklist for the standardised reporting of systematic reviews and meta-analyses of IPD. This has been published</gtr:impact><gtr:outcomeId>56cdd68274bd68.02249865-2</gtr:outcomeId><gtr:partnerContribution>Expertise and intellectual contribution</gtr:partnerContribution><gtr:piContribution>Expertise and intellectual contribution. Steering Group membership (Jayne Tierney)</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>R39 Agreeing current good practice for clinical trial data access and sharing</gtr:description><gtr:id>A730BFB7-E8EF-477C-8234-402BB3EDAF05</gtr:id><gtr:impact>Two papers published giving views on data sharing, rationale and examples</gtr:impact><gtr:outcomeId>56cdc80a144730.74764173-1</gtr:outcomeId><gtr:partnerContribution>MRC Hubs for Trials Methodology Research Network funding provided for project commencement</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded proposal addresses a main priority area for the HTMR Network, that of using existing evidence in the prioritisation, design and planning, conduct, and interpretation of trials, all of which can be helped by improving access to clinical trial data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>BioMarin Pharmaceutical</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>9340ACB7-479B-400D-9236-B07AEFEAF497</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-4</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Saarland University</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>8D26755F-A994-4F56-B13E-A8A7CEC38014</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-9</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trial conduct methodology collaboration</gtr:description><gtr:id>3B3E1D25-5E9D-42A9-9DA0-1378D2515285</gtr:id><gtr:impact>No outcomes to report as yet - collaboration still active</gtr:impact><gtr:outcomeId>56cdd4e2bd4f03.13269513-1</gtr:outcomeId><gtr:partnerContribution>Expertise and intellectual contribution to push forward some specific areas of trial conduct methodological research</gtr:partnerContribution><gtr:piContribution>Expertise and intellectual contribution to push forward some specific areas of trial conduct methodological research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC North West Hub for Trials Methodology Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>B66FB094-8CD2-403B-80AE-2334F63AC306</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-7</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PRISMA-IPD Steering Group</gtr:description><gtr:id>BB939965-DA2E-454E-BEE2-E4AA981F0943</gtr:id><gtr:impact>Development of reporting guidelines and a checklist for the standardised reporting of systematic reviews and meta-analyses of IPD. This has been published</gtr:impact><gtr:outcomeId>56cdd68274bd68.02249865-1</gtr:outcomeId><gtr:partnerContribution>Expertise and intellectual contribution</gtr:partnerContribution><gtr:piContribution>Expertise and intellectual contribution. Steering Group membership (Jayne Tierney)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>425F36CC-2E00-4BC0-B162-28367442015B</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-1</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nottingham Clinical Trials Unit (NCTU)</gtr:department><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>F99BD87C-730D-4D06-9EEE-699BCF4F130D</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-8</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Amgen Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>19001B01-8910-46EA-B156-FEEBF1BCA0E8</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-3</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>005F9F58-CEF2-42C1-A288-E87065E1BBC2</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-1</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Organisation for Research and Treatment of Cancer (EORTC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>R39 Agreeing current good practice for clinical trial data access and sharing</gtr:description><gtr:id>A6AEC57C-30DB-41D3-BC5A-3249628A8ABF</gtr:id><gtr:impact>Two papers published giving views on data sharing, rationale and examples</gtr:impact><gtr:outcomeId>56cdc80a144730.74764173-6</gtr:outcomeId><gtr:partnerContribution>MRC Hubs for Trials Methodology Research Network funding provided for project commencement</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded proposal addresses a main priority area for the HTMR Network, that of using existing evidence in the prioritisation, design and planning, conduct, and interpretation of trials, all of which can be helped by improving access to clinical trial data.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>R20 Workshop and guidance on IPD meta-analysis</gtr:description><gtr:id>2C0EA3D7-28A6-48D0-9893-7AA178174BC3</gtr:id><gtr:impact>We brought international experts to the Unit to discuss key IPD topics, develop guidance outlines and establish writing committees. We have published four papers.</gtr:impact><gtr:outcomeId>56cdc1e24ceb14.55500952-3</gtr:outcomeId><gtr:partnerContribution>Helping develop the funding proposal, project planning, developing the workshop. Drafting and reviewing subsequent IPD guidance papers.</gtr:partnerContribution><gtr:piContribution>Leading the development of the funding proposal, project planning and organising, developing and running a workshop. Drafting and reviewing subsequent IPD guidance papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Methodology Research Collaboration with industry</gtr:description><gtr:id>4C5154B3-0D56-48F1-B305-4A3FA60EC251</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56ced8ec02c142.18830284-1</gtr:outcomeId><gtr:partnerContribution>Commitment to developing research activity in to design, conduct or analysis methodology in areas of mutual interest. Detailed discussions ongoing</gtr:partnerContribution><gtr:piContribution>Commitment to developing research activity in to design, conduct or analysis methodology in areas of mutual interest. Detailed discussions ongoing</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>79F77576-D4D3-4285-892D-088183FC748C</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-6</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>3F02F2BA-B9CF-4F55-A33F-68914ACCE11B</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-4</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Methodology Research Collaboration with industry</gtr:description><gtr:id>FCC96D8E-EF84-4AF3-9E5D-8B1BD5D355C3</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56ced8ec02c142.18830284-2</gtr:outcomeId><gtr:partnerContribution>Commitment to developing research activity in to design, conduct or analysis methodology in areas of mutual interest. Detailed discussions ongoing</gtr:partnerContribution><gtr:piContribution>Commitment to developing research activity in to design, conduct or analysis methodology in areas of mutual interest. Detailed discussions ongoing</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Edinburgh Hub for Trials Methodology Research</gtr:department><gtr:description>R39 Agreeing current good practice for clinical trial data access and sharing</gtr:description><gtr:id>9535D838-3EC1-43BB-A10D-2F6A7B4DF7BB</gtr:id><gtr:impact>Two papers published giving views on data sharing, rationale and examples</gtr:impact><gtr:outcomeId>56cdc80a144730.74764173-4</gtr:outcomeId><gtr:partnerContribution>MRC Hubs for Trials Methodology Research Network funding provided for project commencement</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded proposal addresses a main priority area for the HTMR Network, that of using existing evidence in the prioritisation, design and planning, conduct, and interpretation of trials, all of which can be helped by improving access to clinical trial data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>0356EA0D-6D7E-4BBC-8D3D-B709B4443348</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-7</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Cancer Institute</gtr:department><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>7CCB848A-F7E5-4B6C-8B53-AB3C014CE5EB</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-3</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>F. Hoffmann-La Roche AG</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>50BB573B-F28D-4DEF-B104-7D80291BFA6F</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-5</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts Clinical Trials Unit</gtr:department><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>F5CE62B0-5896-4996-8F3D-2F407F16BDE2</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-5</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>R20 Workshop and guidance on IPD meta-analysis</gtr:description><gtr:id>3A7F481F-95D2-469E-B65A-CE0445A42615</gtr:id><gtr:impact>We brought international experts to the Unit to discuss key IPD topics, develop guidance outlines and establish writing committees. We have published four papers.</gtr:impact><gtr:outcomeId>56cdc1e24ceb14.55500952-5</gtr:outcomeId><gtr:partnerContribution>Helping develop the funding proposal, project planning, developing the workshop. Drafting and reviewing subsequent IPD guidance papers.</gtr:partnerContribution><gtr:piContribution>Leading the development of the funding proposal, project planning and organising, developing and running a workshop. Drafting and reviewing subsequent IPD guidance papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ORRCA - Online Resource for Recruitment research in Clinical triAls</gtr:description><gtr:id>EF3B9B5B-1BC0-48ED-844D-18E2FCE1BAF5</gtr:id><gtr:impact>ORRCA database.</gtr:impact><gtr:outcomeId>5888d801a4f2f3.86949220-1</gtr:outcomeId><gtr:partnerContribution>Development of, and overall responsibility for resource and related publications.</gtr:partnerContribution><gtr:piContribution>Categorisation of research papers for the ORRCA recruitment database.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical Trials Unit (CTU) Glasgow</gtr:department><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>59EFC26C-5A4C-4BC6-9997-D1C4E631926B</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-9</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hub at the MRC/CRUK/BHF Clinical Trial Service Unit</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>R39 Agreeing current good practice for clinical trial data access and sharing</gtr:description><gtr:id>135ECB56-9ACE-45D0-8222-67F861F04E16</gtr:id><gtr:impact>Two papers published giving views on data sharing, rationale and examples</gtr:impact><gtr:outcomeId>56cdc80a144730.74764173-3</gtr:outcomeId><gtr:partnerContribution>MRC Hubs for Trials Methodology Research Network funding provided for project commencement</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded proposal addresses a main priority area for the HTMR Network, that of using existing evidence in the prioritisation, design and planning, conduct, and interpretation of trials, all of which can be helped by improving access to clinical trial data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UKCRC Registered CTUs Network: Participant data sharing group</gtr:description><gtr:id>A0B98558-4071-49E9-B71A-F3C0D4E92361</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:outcomeId>56d81505592ce5.43099861-2</gtr:outcomeId><gtr:partnerContribution>Partners are involved in a working group to facilitate the implementation of data sharing good practice across the UKCRC registered CTU network, to provide advice and support to CTUs about data sharing, and to liaise with external organisations regarding data sharing.</gtr:partnerContribution><gtr:piContribution>Member of the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PRISMA-IPD Steering Group</gtr:description><gtr:id>78E3EA64-10CB-4C53-A7C0-D4CF4E84872C</gtr:id><gtr:impact>Development of reporting guidelines and a checklist for the standardised reporting of systematic reviews and meta-analyses of IPD. This has been published</gtr:impact><gtr:outcomeId>56cdd68274bd68.02249865-4</gtr:outcomeId><gtr:partnerContribution>Expertise and intellectual contribution</gtr:partnerContribution><gtr:piContribution>Expertise and intellectual contribution. Steering Group membership (Jayne Tierney)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>EFSPI/PSI Data Sharing Working Group</gtr:description><gtr:id>2EA8A30D-6B96-492A-A0F5-35E3250668C6</gtr:id><gtr:impact>Series of manuscripts outlining best practice for preparation and analysis of shared clinical trial data is in preparation (two submitted)</gtr:impact><gtr:outcomeId>56d817e36c19f8.98962810-10</gtr:outcomeId><gtr:partnerContribution>Aims of the working group are:
?To identify and prospectively prioritize statistical issues in data transparency
?To co-ordinate statistical contributions across Europe to the data transparency debate
?To disseminate relevant information on the topic across the statistical community
?To develop and share a vision of the potential longer term impact of data transparency.
Members of the collaboration led the working group, all partners involved in planning and contributing to manuscripts</gtr:partnerContribution><gtr:piContribution>Input into an EFSPI / PSI working group and conrtibution to manuscript development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Midland Hub for Trials Methodology Research (MHTMR)</gtr:department><gtr:description>R39 Agreeing current good practice for clinical trial data access and sharing</gtr:description><gtr:id>60899E16-DAF4-4E09-A606-97B32DCCB6C1</gtr:id><gtr:impact>Two papers published giving views on data sharing, rationale and examples</gtr:impact><gtr:outcomeId>56cdc80a144730.74764173-5</gtr:outcomeId><gtr:partnerContribution>MRC Hubs for Trials Methodology Research Network funding provided for project commencement</gtr:partnerContribution><gtr:piContribution>MRC Hubs for Trials Methodology Research Network funded proposal addresses a main priority area for the HTMR Network, that of using existing evidence in the prioritisation, design and planning, conduct, and interpretation of trials, all of which can be helped by improving access to clinical trial data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Festival Workshop on Getting Results Faster for Patients</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>77341368-0FE6-436F-9FA0-040220362E4A</gtr:id><gtr:impact>As part of the Medical Research Council (MRC) Festival of Medical Research, the MRC Clinical Trials Unit at University College London (MRC CTU at UCL) held a half-day workshop exploring how the Unit is working to get faster results and impact from clinical trials. We invited patient representatives involved in our studies, and patient groups who are interested in clinical trials. 30 people from 20 patient groups and various trials attended the workshop, along with around 20 members of MRC CTU at UCL staff.</gtr:impact><gtr:outcomeId>58ac48ecd3e231.69350368</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.ctu.mrc.ac.uk/news/2016/getting_results_faster_workshop_report_010816</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Twitter Q+A session: #fastertrials #fasterimpact</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>217BCF40-C581-4E7A-9699-BB3932DBE929</gtr:id><gtr:impact>Held a Twitter Q+A as part of the MRC Festival of medical research 2016. It focused on how to speed up both the conduct of trials and the impact of these trials' results.</gtr:impact><gtr:outcomeId>58a6df12220104.13543199</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ctu.mrc.ac.uk/news/2016/faster_trials_qa_230616</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Hub for Trials Methodology Research (HTMR) - extension</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7E30F6A7-8836-455D-81DE-1435E47554F8</gtr:id><gtr:outcomeId>54645fa71eaec3.35395841</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Research Panel: Missing data in propensity score analyses of Electronic Health Records Data</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M013278/1</gtr:fundingRef><gtr:id>557152B4-188B-45FD-9E0C-7E41D9606D49</gtr:id><gtr:outcomeId>56d97fe7d25bb1.80044989</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>205540</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CR UK Population Science Committee, Project Grant (TEMPER study)</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C1495/A13305</gtr:fundingRef><gtr:id>FA3CC71C-BB48-493D-8A82-DB5FD76059DB</gtr:id><gtr:outcomeId>56ceda63f34ff1.71373002</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Guidance on sharing of data from publicly funded trials</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3CA4B0BE-168C-40AE-AD04-15FEA4DD6E96</gtr:id><gtr:outcomeId>56defe8a14eb93.67273030</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.ct-toolkit.ac.uk/routemap/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Patient Information Sheet template and guidance referenced in HRA guidance</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC035AFC-B881-46F0-AC51-4DB95D2E0197</gtr:id><gtr:outcomeId>58b7faf34f9803.88877863</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.hra.nhs.uk/documents/2017/01/applying-proportionate-approach-process-seeking-consent.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Data sharing guidance cited in CRUK guidance</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>89B37F21-9FE1-487D-97B1-3521D01BF431</gtr:id><gtr:outcomeId>58b9306d4e40e4.50549732</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>http://www.cancerresearchuk.org/sites/default/files/hands_on_data_sharing_advice_-_clinical.pdf</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New Patient Information Sheet template and associated guidance, developed for use at the CTU but shared externally with over 60 other researchers (so far).</gtr:description><gtr:id>DFF41864-F27C-4B47-B476-0254241AEB7C</gtr:id><gtr:impact>HRA is due to include a reference to this tool in their updated PIS guidance.</gtr:impact><gtr:outcomeId>5888dadb096395.80262145</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PIS template</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ctu.mrc.ac.uk/resources/patient_involvement/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>The Stata package &amp;quot;ipdmetan&amp;quot; comprises a set of routines for conducting two-stage individual participant data (IPD) meta-analysis, and associated functionality.</gtr:description><gtr:id>6DCE40FA-5A48-4361-90CD-E2CD2CE7C055</gtr:id><gtr:impact>The package is available from the SSC archive and can be found and installed from within Stata by typing &amp;quot;ssc describe ipdmetan&amp;quot; and &amp;quot;ssc install ipdmetan&amp;quot; respectively. A Stata Journal article describing the functionality of the package has been published</gtr:impact><gtr:outcomeId>56cee5b5844a94.08309933</gtr:outcomeId><gtr:title>STATA CODE FOR PERFORMING TWO-STAGE INDIVIDUAL PARTICIPANT DATA META-ANALYSIS</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://econpapers.repec.org/software/bocbocode/s457785.htm</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7C953951-83A5-40AA-9636-15F575246B8A</gtr:id><gtr:title>Exploring the role and function of trial steering committees: results of an expert panel meeting.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/563710b15a31a4a26184221dac7791dd"><gtr:id>563710b15a31a4a26184221dac7791dd</gtr:id><gtr:otherNames>Harman NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>56d6f9644da641.73305068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC0D3AC8-C891-4419-A036-AC3BF5A5572D</gtr:id><gtr:title>Best practice guidance for the use of strategies to improve retention in&amp;nbsp;randomized trials developed from two consensus workshops.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be104b9f859b1182f6dcc12403f7d6ec"><gtr:id>be104b9f859b1182f6dcc12403f7d6ec</gtr:id><gtr:otherNames>Brueton V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>5a941a7a6ef353.31495711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C30CF63F-06CF-4B94-ACF3-E6CFBA892370</gtr:id><gtr:title>Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/832df148756d511657c37e271ee13c54"><gtr:id>832df148756d511657c37e271ee13c54</gtr:id><gtr:otherNames>Savovic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>5a941a7b2280d3.65600107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01F76C6C-F921-4FC2-BF8C-5CFC0AB52506</gtr:id><gtr:title>Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences.</gtr:title><gtr:parentPublicationTitle>Clinical trials (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a328dde90a8c07550067687ea668cc31"><gtr:id>a328dde90a8c07550067687ea668cc31</gtr:id><gtr:otherNames>Conroy EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1740-7745</gtr:issn><gtr:outcomeId>56cdad50265e46.48536393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3799422-E9A3-48E4-BF03-F1CCF691D8C9</gtr:id><gtr:title>Two-stage individual participant data meta-analysis and generalized forest plots</gtr:title><gtr:parentPublicationTitle>STATA JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f82c63bf6cce54a4d2b17c45990296ac"><gtr:id>f82c63bf6cce54a4d2b17c45990296ac</gtr:id><gtr:otherNames>Fisher David J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1536-867X</gtr:issn><gtr:outcomeId>56cda98e955163.35022889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ACD86F3-F2E8-4B66-9678-4A9654AA18A8</gtr:id><gtr:title>Quantifying the uptake of user-written commands over time</gtr:title><gtr:parentPublicationTitle>STATA JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83dd8b15142e903637fcb1c70faff1cb"><gtr:id>83dd8b15142e903637fcb1c70faff1cb</gtr:id><gtr:otherNames>Choodari-Oskooei Babak</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1536-867X</gtr:issn><gtr:outcomeId>5888d0b3db1df4.37974997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F63FB6E3-D77E-4223-9798-2B9976969FE1</gtr:id><gtr:title>Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7156ed1abac4e2954cb30a3009a9d087"><gtr:id>7156ed1abac4e2954cb30a3009a9d087</gtr:id><gtr:otherNames>Stewart LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>56cda9f4167a24.00092086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEF76163-394C-4FD6-AE6D-5AEEF0AF9717</gtr:id><gtr:title>Sharing data from clinical trials: the rationale for a controlled access approach.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bc86594b102aaa9a8a5b2a19fee8e4"><gtr:id>a3bc86594b102aaa9a8a5b2a19fee8e4</gtr:id><gtr:otherNames>Sydes MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>56cdab1fe151c0.33103134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F6CFF37-FD6B-40F2-94FB-34523EC3DB7F</gtr:id><gtr:title>Global health trials methodological research agenda: results from a priority setting exercise.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a169e5f3502be1057cae26977fbbafbc"><gtr:id>a169e5f3502be1057cae26977fbbafbc</gtr:id><gtr:otherNames>Rosala-Hallas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a941a7b755689.77281409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF37E973-E631-47E8-9264-C87730C46AF5</gtr:id><gtr:title>Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7744e8e09b3d0fd0cf776341fadf5194"><gtr:id>7744e8e09b3d0fd0cf776341fadf5194</gtr:id><gtr:otherNames>South A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5888cc6d6efaa9.82273179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>577F4BB2-E2E1-414E-B756-87C718E8F068</gtr:id><gtr:title>The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82ec9626d58a4ea466eaa55b6c04426a"><gtr:id>82ec9626d58a4ea466eaa55b6c04426a</gtr:id><gtr:otherNames>Clayton GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a941a7ab299b5.89931478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0A517D6-CC49-491A-8237-BC65A021C9C3</gtr:id><gtr:title>Identifying additional studies for a systematic review of retention strategies in randomised controlled trials: making contact with trials units and trial methodologists.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be104b9f859b1182f6dcc12403f7d6ec"><gtr:id>be104b9f859b1182f6dcc12403f7d6ec</gtr:id><gtr:otherNames>Brueton V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>5a941a7a901241.25482442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04D2720E-118B-4475-9A85-D0E6E5338157</gtr:id><gtr:title>Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.</gtr:title><gtr:parentPublicationTitle>HIV medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ace442991d80db8655f18f8d0589d70"><gtr:id>2ace442991d80db8655f18f8d0589d70</gtr:id><gtr:otherNames>Denning E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1464-2662</gtr:issn><gtr:outcomeId>56cdab018c3907.65046634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40C72EE5-A13B-411C-BC5C-3AF377A21EB0</gtr:id><gtr:title>Best practice for analysis of shared clinical trial data.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94b1851daf641b11eaa6b1181c68ff63"><gtr:id>94b1851daf641b11eaa6b1181c68ff63</gtr:id><gtr:otherNames>Hollis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>58b70f243c1d80.55220103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E905007B-8E54-4B6A-8313-9F3C9114D3DF</gtr:id><gtr:title>How individual participant data meta-analyses have influenced trial design, conduct, and analysis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/663c60b99db378e47bc2ef1efd6bb108"><gtr:id>663c60b99db378e47bc2ef1efd6bb108</gtr:id><gtr:otherNames>Tierney JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>56cdaa241f71c2.55999703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E3CBDA6-CDEF-482C-9D49-B95AA064B7A3</gtr:id><gtr:title>Data sharing and the evolving role of statisticians.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4b35b0e854d65b8d6a20af4759feb95"><gtr:id>a4b35b0e854d65b8d6a20af4759feb95</gtr:id><gtr:otherNames>Manamley N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>5888cc23636ca0.41728822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD55C02F-2921-40AA-AB10-3D7CC89DD5B2</gtr:id><gtr:title>Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21f668352004702303f2e8e0e2b26d93"><gtr:id>21f668352004702303f2e8e0e2b26d93</gtr:id><gtr:otherNames>Vale CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>56cda9cb22e953.27586100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3072D694-A4C3-4ECA-A69C-1254EE16A50D</gtr:id><gtr:title>What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c92f3c66fa53b6ec7c71818d337ada01"><gtr:id>c92f3c66fa53b6ec7c71818d337ada01</gtr:id><gtr:otherNames>Daykin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5888caf6197904.46045526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>058C82A4-83F4-4040-B073-1FDD7FA4D9B6</gtr:id><gtr:title>When participants get involved: reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21f668352004702303f2e8e0e2b26d93"><gtr:id>21f668352004702303f2e8e0e2b26d93</gtr:id><gtr:otherNames>Vale CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a941a7b9523a1.44915710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>600BDB04-FE99-4543-A366-14EBEC496C10</gtr:id><gtr:title>UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50c53ac5efc52c6e7ca263d0bf9ed86a"><gtr:id>50c53ac5efc52c6e7ca263d0bf9ed86a</gtr:id><gtr:otherNames>Hopkins C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>5888cb9d8006d3.26650859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C66CDA2-3301-473F-B611-86828AD364FF</gtr:id><gtr:title>Major Greenwood (1880-1949): a biographical and bibliographical study.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8e4acfc564c4a9e7aaa421228e10cc6"><gtr:id>a8e4acfc564c4a9e7aaa421228e10cc6</gtr:id><gtr:otherNames>Farewell V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>5888d150146159.86241807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12E9F971-8E4F-4CD4-8100-36E4F6D58F4C</gtr:id><gtr:title>A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a328dde90a8c07550067687ea668cc31"><gtr:id>a328dde90a8c07550067687ea668cc31</gtr:id><gtr:otherNames>Conroy EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a941a7adb8720.98106260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B179A008-0F15-4DED-807C-79045024804B</gtr:id><gtr:title>A randomized trial comparing concise and standard consent forms in the START trial.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d636c85036b37f83259ba7ece408e8ab"><gtr:id>d636c85036b37f83259ba7ece408e8ab</gtr:id><gtr:otherNames>Grady C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a941a7a4941c6.27900315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47946869-B9EC-4650-802F-75BA8576C052</gtr:id><gtr:title>ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da567e0749728cb450f3e0581d24435d"><gtr:id>da567e0749728cb450f3e0581d24435d</gtr:id><gtr:otherNames>Sterne JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>58c01abc7589d8.34122278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10A5EA78-DEF6-4C92-AAFF-DE30C5FF6B91</gtr:id><gtr:title>Outcomes and endpoints in cancer trials: bridging the divide.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/477b885db33d0da24a7c79afa28589e7"><gtr:id>477b885db33d0da24a7c79afa28589e7</gtr:id><gtr:otherNames>Wilson MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>56cdaacaf28117.23402054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01BD5C40-2DB0-44BD-9756-15338F79F7FE</gtr:id><gtr:title>'We all want to succeed, but we've also got to be realistic about what is happening': an ethnographic study of relationships in trial oversight and their impact.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c92f3c66fa53b6ec7c71818d337ada01"><gtr:id>c92f3c66fa53b6ec7c71818d337ada01</gtr:id><gtr:otherNames>Daykin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a941a7b050089.57031485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>727A8937-52AA-459C-8588-EAD0AB428C61</gtr:id><gtr:title>INVESTIGATING THE EFFICACY OF CLINICAL TRIAL MONITORING STRATEGIES: Design and Implementation of the Cluster Randomized START Monitoring Substudy.</gtr:title><gtr:parentPublicationTitle>Therapeutic innovation &amp; regulatory science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0704d138e3c0a95580fdc2cabc6682ca"><gtr:id>0704d138e3c0a95580fdc2cabc6682ca</gtr:id><gtr:otherNames>Hullsiek KH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2168-4790</gtr:issn><gtr:outcomeId>56cc4a7c330742.23551057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E03DEA1-8E7D-4D1F-8B1F-498A6AEE7D9E</gtr:id><gtr:title>Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59fac098248b340aabd71315601019f7"><gtr:id>59fac098248b340aabd71315601019f7</gtr:id><gtr:otherNames>Treweek S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>56cdadac9d6ea3.43949510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>616B9A1A-52D6-430D-AAE6-087CA28B5080</gtr:id><gtr:title>Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/663c60b99db378e47bc2ef1efd6bb108"><gtr:id>663c60b99db378e47bc2ef1efd6bb108</gtr:id><gtr:otherNames>Tierney JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56cdaa61003736.23674758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CAF9304-E83D-4B24-B206-B6CBA82F341E</gtr:id><gtr:title>Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials</gtr:title><gtr:parentPublicationTitle>Clinical Investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b9e5043e2b9b0699c235d213fd2957a"><gtr:id>2b9e5043e2b9b0699c235d213fd2957a</gtr:id><gtr:otherNames>Thomason M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cdacc5423108.33263189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D1404D7-FC2B-435D-B9D2-894BAB93B5E2</gtr:id><gtr:title>Data Authorship as an Incentive to Data Sharing.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bc86594b102aaa9a8a5b2a19fee8e4"><gtr:id>a3bc86594b102aaa9a8a5b2a19fee8e4</gtr:id><gtr:otherNames>Sydes MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5a941a7b4acb92.84724100</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12023/24</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>